BDBM414010 US10421760, Comparative Example 11(a)::US10421760, Comparative Example 11(b)

SMILES C=CC(=O)N[C@H]1CCCC(C1)c1ncnc2[nH]cc(-c3ccco3)c12

InChI Key InChIKey=QCKWDCZXABIMQD-UHFFFAOYSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 414010   

TargetTyrosine-protein kinase JAK3(Human)
Taiho Pharmaceutical

US Patent
LigandPNGBDBM414010(US10421760, Comparative Example 11(a) | US10421760...)
Affinity DataIC50: 19nMAssay Description:JAK3: Among materials for the measurement of this inhibiting activity, a substrate peptide and a kinase protein were acquired as follows. As such a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Taiho Pharmaceutical

US Patent
LigandPNGBDBM414010(US10421760, Comparative Example 11(a) | US10421760...)
Affinity DataIC50: 21nMAssay Description:JAK3: Among materials for the measurement of this inhibiting activity, a substrate peptide and a kinase protein were acquired as follows. As such a s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Taiho Pharmaceutical

US Patent
LigandPNGBDBM414010(US10421760, Comparative Example 11(a) | US10421760...)
Affinity DataIC50: 880nMAssay Description:JAK 2: Among materials for the measurement of this inhibiting activity, a substrate peptide and a kinase protein were acquired as follows. As such a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Taiho Pharmaceutical

US Patent
LigandPNGBDBM414010(US10421760, Comparative Example 11(a) | US10421760...)
Affinity DataIC50: 2.44E+3nMAssay Description:JAK 2: Among materials for the measurement of this inhibiting activity, a substrate peptide and a kinase protein were acquired as follows. As such a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Taiho Pharmaceutical

US Patent
LigandPNGBDBM414010(US10421760, Comparative Example 11(a) | US10421760...)
Affinity DataIC50: 1.00E+4nMAssay Description:JAK 1: Among materials for the measurement of this inhibiting activity, a substrate peptide and a kinase protein were acquired as follows. As such a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Taiho Pharmaceutical

US Patent
LigandPNGBDBM414010(US10421760, Comparative Example 11(a) | US10421760...)
Affinity DataIC50: 1.00E+4nMAssay Description:JAK 1: Among materials for the measurement of this inhibiting activity, a substrate peptide and a kinase protein were acquired as follows. As such a ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2020
Entry Details
US Patent